Clinical Trial

Incidence and Risk Factor of Drug Related Problem Detected in Inpatient

Study acronym: DRPINPAT
Recruiting
View on ClinicalTrials.gov →
Summary
Drug Related Problem (DRP) is defined as an event that may potentially affect the health outcomes in the patients. DRPs can occur at all stages of the medication usage process starting from prescribing to dispensing stage. Lack of follow-ups and reassessment of therapeutic outcomes may also contribute to DRPs. Pharmaceutical care is a co-operative activity in concert with other health care professionals and offered directly to the patient for improved quality use of medicines and achieving achieve the desired therapeutic outcomes. Pharmaceutical care identifies and resolves actual or potential DRPs. DRPs pose a challenge to the clinician, and that may affect patient's clinical outcomes and may result in morbidity or mortality and increased health care costs. Health care costs may become a burden to the patient or may be to the government or to the third parties. Clinical Pharmacy is a discipline that promotes the quality use of medicines through evidence-based medicine and helps in identification and resolving DRPs. A clinical pharmacist through his/her clinical accuracy checking may identify DRPs and come out with suitable solutions to resolve the same. Consequently, the aims of our study were to assess prevalence and characteristics of DRPs identified in inpatient and to identify factors associated with DRPs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2018-03-19; most recent amendment 2020-06-04.
Trial Details
NCT Number NCT03476733
Lead Sponsor University Hospital, Montpellier
Conditions Drug Related Problem
Enrollment 20,000 participants
Start Date 2016-01-01
Primary Completion 2035-11-01 (estimated)
Study Completion 2036-01-01 (estimated)
Updated on ClinicalTrials.gov 2020-06-05